Your session is about to expire
← Back to Search
Exercise Intervention for Down Syndrome
N/A
Recruiting
Led By Thessa Hilgenkamp, PhD
Research Sponsored by University of Nevada, Las Vegas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Must not have
Diabetes (defined as Hba1c of >7.5% or use of glucose lowering medication)
Atherosclerotic or other vascular disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 13 weeks
Summary
This trial looks at the effects of exercise on people with Down Syndrome, specifically how it affects blood flow and cardiac function. They also want to see how exercise affects balance, walking, and attitude.
Who is the study for?
This trial is for generally healthy, sedentary adults with Down syndrome who have normal or stable thyroid function. It's not open to those with heart disease, vascular issues, severe lung conditions, uncontrolled blood pressure, a history of fainting episodes, diabetes, extreme obesity, or those on certain medications affecting the heart and arteries.
What is being tested?
The study is testing how well people with Down syndrome respond to exercise training in terms of blood flow regulation and cardiac function. Participants will either receive combined exercise interventions or usual care to see if there are improvements in their peak oxygen consumption.
What are the potential side effects?
While specific side effects aren't listed for this trial since it involves exercise intervention rather than medication, typical risks might include muscle soreness or injury from physical activity.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have diabetes with an HbA1c over 7.5% or I am on medication to lower my blood sugar.
Select...
I have a condition related to hardening of the arteries.
Select...
I am currently taking anti-inflammatory medication.
Select...
I have a history of fainting or nearly fainting.
Select...
I was born with a heart condition.
Select...
I am not on medications that affect my heart rate, blood pressure, or arteries.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 13 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~13 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change from Baseline Work capacity at 13 weeks
Secondary study objectives
Change from Baseline Autonomic cardiac function at rest at 13 weeks
Change from Baseline Autonomic cardiac function during orthostasis at 13 weeks
Change from Baseline Brachial blood flow at 13 weeks
+12 moreTrial Design
3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Combined exercise intervention Down syndromeExperimental Treatment1 Intervention
The exercise intervention will last 12 weeks and will consist of a supervised combined aerobic and resistance training program with a frequency of 3 days/week.In the exercise sessions, the participant will work with the trainer on their strength, balance and aerobic endurance. Each session consists of 10 min of strength exercises (Foundational Exercise), 10 min of Hip Strengthening, 10 min of Vestibular and Balance Exercise, and 20 min of Aerobic Exercise, and starts with a warming up and ends with stretching/cooling down. Each new exercise will be introduced in easy steps and practiced until the participant is comfortable executing it.
Group II: Reference group without Down syndromeActive Control1 Intervention
This reference group of age- and sex-matched inactive individuals without Down syndrome will undergo the same baseline testing as the other groups but without intervention or post-intervention measures.
Group III: Usual care Down SyndromePlacebo Group1 Intervention
The control condition consists of usual activities.
Find a Location
Who is running the clinical trial?
University of Nevada, Las VegasLead Sponsor
73 Previous Clinical Trials
13,978 Total Patients Enrolled
2 Trials studying Down Syndrome
48 Patients Enrolled for Down Syndrome
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,049 Previous Clinical Trials
2,731,085 Total Patients Enrolled
16 Trials studying Down Syndrome
145,379 Patients Enrolled for Down Syndrome
Thessa Hilgenkamp, PhDPrincipal InvestigatorUniversity of Nevada, Las Vegas
1 Previous Clinical Trials
21 Total Patients Enrolled
1 Trials studying Down Syndrome
21 Patients Enrolled for Down Syndrome
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have high blood pressure (defined as blood pressure higher than 140/90 mmHg).I have Down syndrome with normal or stable thyroid function for at least 6 months.You are extremely overweight with a body mass index (BMI) over 40.Your blood pressure is lower than 90/60 mmHg.I have diabetes with an HbA1c over 7.5% or I am on medication to lower my blood sugar.I do less than 30 minutes of moderate exercise daily.I have a condition related to hardening of the arteries.I am currently taking anti-inflammatory medication.I have asthma or another lung condition.I have a history of fainting or nearly fainting.I was born with a heart condition.You are currently smoking.I am not on medications that affect my heart rate, blood pressure, or arteries.
Research Study Groups:
This trial has the following groups:- Group 1: Reference group without Down syndrome
- Group 2: Combined exercise intervention Down syndrome
- Group 3: Usual care Down Syndrome
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger